Edition:
United States

PerkinElmer Inc (PKI.N)

PKI.N on New York Stock Exchange

63.47USD
18 Aug 2017
Change (% chg)

$-0.19 (-0.30%)
Prev Close
$63.66
Open
$63.56
Day's High
$63.94
Day's Low
$63.20
Volume
138,342
Avg. Vol
171,814
52-wk High
$70.16
52-wk Low
$47.00

PKI.N

Chart for PKI.N

About

PerkinElmer, Inc. is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food,... (more)

Overall

Beta: 0.77
Market Cap(Mil.): $6,995.32
Shares Outstanding(Mil.): 110.21
Dividend: 0.07
Yield (%): 0.44

Financials

  PKI.N Industry Sector
P/E (TTM): 34.03 118.44 32.56
EPS (TTM): 1.87 -- --
ROI: 5.38 9.54 14.89
ROE: 9.09 14.77 16.13

BRIEF-PerkinElmer enters into 364-day unsecured term loan facility

* PerkinElmer Inc - ‍on August 11, entered into a 364-day unsecured term loan facility in principal amount of $200 million - SEC filing​

Aug 15 2017

REFILE-BRIEF-PerkinElmer launches clinical whole genome sequencing services

* PerkinElmer launches clinical whole genome sequencing services

Aug 04 2017

PerkinElmer profit meets Street view, boosts 2017 forecast range

Scientific instruments maker PerkinElmer Inc on Thursday posted a second-quarter profit that matched expectations and boosted its full-year earnings forecast range with a new midpoint slightly ahead of Wall Street estimates.

Aug 03 2017

UPDATE 1-PerkinElmer profit meets Street view, boosts 2017 forecast range

Aug 3 Scientific instruments maker PerkinElmer Inc on Thursday posted a second-quarter profit that matched expectations and boosted its full-year earnings forecast range with a new midpoint slightly ahead of Wall Street estimates.

Aug 03 2017

BRIEF-PerkinElmer reports Q2 GAAP EPS from continuing operations $0.57

* Q2 GAAP earnings per share from continuing operations $0.57; Q2 adjusted earnings per share $0.67; Q2 GAAP revenue $547.0 million versus $536.2 million

Aug 03 2017

PerkinElmer profit meets Street view, raises 2017 forecast

Aug 3 Scientific instruments maker PerkinElmer Inc on Thursday reported second quarter profit that matched expectations and boosted its full-year earnings forecast range with a new midpoint slightly ahead of Wall Street estimates.

Aug 03 2017

PerkinElmer to buy Germany's Euroimmun for about $1.3 billion

Scientific instruments maker PerkinElmer Inc said on Monday it would buy Germany's Euroimmun Medical Laboratory Diagnostics AG for about $1.3 billion in cash to expand its reach into autoimmune and allergy diagnostic markets.

Jun 19 2017

UPDATE 1-PerkinElmer to buy Germany's Euroimmun for about $1.3 bln

June 19 Scientific instruments maker PerkinElmer Inc said on Monday it would buy Germany's Euroimmun Medical Laboratory Diagnostics AG for about $1.3 billion in cash to expand its reach into autoimmune and allergy diagnostic markets.

Jun 19 2017

PerkinElmer to buy Germany's Euroimmun for about $1.3 bln

June 19 Scientific instruments maker PerkinElmer Inc said on Monday it would buy Germany's Euroimmun Medical Laboratory Diagnostics AG for about $1.3 billion in cash.

Jun 19 2017

BRIEF-PerkinElmer to acquire Euroimmun for about $1.3 bln

* PerkinElmer to acquire Euroimmun for approximately $1.3 billion

Jun 19 2017

Competitors

Earnings vs. Estimates